Keywords: eurand, zentase, bioavailable, study, dutch, drug, developer

Eurand's Zentase is bioavailable in study

Article | 10 December 2007

Dutch drug developer Eurand NV has completed a gastrointestinal bioavailability study on Zentase (EUR-1008), the company's lead product candidate for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eurand

Go to company listing